Amalgam exposure and neurological function

Albert Kingman, James W. Albers, Joseph C. Arezzo, David H. Garabrant, Joel E. Michalek

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Concerns regarding the safety of silver-mercury amalgam fillings continue to be raised in the absence of any direct evidence of harm. The widespread population exposure to amalgam mandated that a thorough investigation be conducted of its potential effects on the nervous system. The National Institute of Dental and Craniofacial Research and U.S. Air Force investigators collaborated in the ongoing Air Force Health Study (AFHS) of Vietnam era veterans. The primary study question involved adverse health effects associated with exposure to herbicides or dioxin. An assessment of exposure to dental amalgam fillings was added to the 1997-1998 health examination to investigate possible associations between amalgam exposure and neurological abnormalities. Our study population consisted of 1663 dentate AFHS participants, comprised of 986 AFHS controls and 677 Ranch Hand veterans who were exposed to dioxin in Vietnam. Two hundred and fifty-two of the participants had confirmed diabetes mellitus. Study outcomes included clinical neurological signs, vibrotactile thresholds, and summary variables for different levels of peripheral neuropathy. A limitation of our study is that our database did not include more sensitive continuous measures such as nerve conduction studies. No significant associations were found between amalgam exposure and clinical neurological signs of abnormal tremor, coordination, station or gait, strength, sensation, or muscle stretch reflexes or for any level of peripheral neuropathy among our study participants. A statistically significant association was detected between amalgam exposure and the continuous vibrotactile sensation response for the combined non-diabetic participants and separately for non-diabetic AFHS controls. No significant association in this measure was detectable for non-diabetic Ranch Hand veterans or among the combined diabetic participants. The association is a sub-clinical finding that was not associated with symptoms, clinically evident signs of neuropathy, or any functional impairment. Overall, we found no association between amalgam exposure and neurological signs or clinically evident peripheral neuropathy. Our findings do not support the hypothesis that exposure to amalgam produces adverse, clinically evident neurological effects.

Original languageEnglish (US)
Pages (from-to)241-255
Number of pages15
JournalNeuroToxicology
Volume26
Issue number2
DOIs
StatePublished - Mar 2005

Fingerprint

Mercury amalgams
Health
Air
Peripheral Nervous System Diseases
Veterans
Dioxins
Vietnam
National Institute of Dental and Craniofacial Research (U.S.)
Hand
Dental Amalgam
Stretch Reflex
Neural Conduction
Neurology
Herbicides
Tremor
Medical problems
Gait
Nervous System
Population
Muscle

Keywords

  • Amalgam exposure
  • Epidemiology
  • Mercury
  • Neurological signs
  • Peripheral neuropathy

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Neuroscience(all)
  • Toxicology

Cite this

Kingman, A., Albers, J. W., Arezzo, J. C., Garabrant, D. H., & Michalek, J. E. (2005). Amalgam exposure and neurological function. NeuroToxicology, 26(2), 241-255. https://doi.org/10.1016/j.neuro.2004.09.008

Amalgam exposure and neurological function. / Kingman, Albert; Albers, James W.; Arezzo, Joseph C.; Garabrant, David H.; Michalek, Joel E.

In: NeuroToxicology, Vol. 26, No. 2, 03.2005, p. 241-255.

Research output: Contribution to journalArticle

Kingman, A, Albers, JW, Arezzo, JC, Garabrant, DH & Michalek, JE 2005, 'Amalgam exposure and neurological function', NeuroToxicology, vol. 26, no. 2, pp. 241-255. https://doi.org/10.1016/j.neuro.2004.09.008
Kingman A, Albers JW, Arezzo JC, Garabrant DH, Michalek JE. Amalgam exposure and neurological function. NeuroToxicology. 2005 Mar;26(2):241-255. https://doi.org/10.1016/j.neuro.2004.09.008
Kingman, Albert ; Albers, James W. ; Arezzo, Joseph C. ; Garabrant, David H. ; Michalek, Joel E. / Amalgam exposure and neurological function. In: NeuroToxicology. 2005 ; Vol. 26, No. 2. pp. 241-255.
@article{8f2d324fa335405c8799a69b03adf0a6,
title = "Amalgam exposure and neurological function",
abstract = "Concerns regarding the safety of silver-mercury amalgam fillings continue to be raised in the absence of any direct evidence of harm. The widespread population exposure to amalgam mandated that a thorough investigation be conducted of its potential effects on the nervous system. The National Institute of Dental and Craniofacial Research and U.S. Air Force investigators collaborated in the ongoing Air Force Health Study (AFHS) of Vietnam era veterans. The primary study question involved adverse health effects associated with exposure to herbicides or dioxin. An assessment of exposure to dental amalgam fillings was added to the 1997-1998 health examination to investigate possible associations between amalgam exposure and neurological abnormalities. Our study population consisted of 1663 dentate AFHS participants, comprised of 986 AFHS controls and 677 Ranch Hand veterans who were exposed to dioxin in Vietnam. Two hundred and fifty-two of the participants had confirmed diabetes mellitus. Study outcomes included clinical neurological signs, vibrotactile thresholds, and summary variables for different levels of peripheral neuropathy. A limitation of our study is that our database did not include more sensitive continuous measures such as nerve conduction studies. No significant associations were found between amalgam exposure and clinical neurological signs of abnormal tremor, coordination, station or gait, strength, sensation, or muscle stretch reflexes or for any level of peripheral neuropathy among our study participants. A statistically significant association was detected between amalgam exposure and the continuous vibrotactile sensation response for the combined non-diabetic participants and separately for non-diabetic AFHS controls. No significant association in this measure was detectable for non-diabetic Ranch Hand veterans or among the combined diabetic participants. The association is a sub-clinical finding that was not associated with symptoms, clinically evident signs of neuropathy, or any functional impairment. Overall, we found no association between amalgam exposure and neurological signs or clinically evident peripheral neuropathy. Our findings do not support the hypothesis that exposure to amalgam produces adverse, clinically evident neurological effects.",
keywords = "Amalgam exposure, Epidemiology, Mercury, Neurological signs, Peripheral neuropathy",
author = "Albert Kingman and Albers, {James W.} and Arezzo, {Joseph C.} and Garabrant, {David H.} and Michalek, {Joel E.}",
year = "2005",
month = "3",
doi = "10.1016/j.neuro.2004.09.008",
language = "English (US)",
volume = "26",
pages = "241--255",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Amalgam exposure and neurological function

AU - Kingman, Albert

AU - Albers, James W.

AU - Arezzo, Joseph C.

AU - Garabrant, David H.

AU - Michalek, Joel E.

PY - 2005/3

Y1 - 2005/3

N2 - Concerns regarding the safety of silver-mercury amalgam fillings continue to be raised in the absence of any direct evidence of harm. The widespread population exposure to amalgam mandated that a thorough investigation be conducted of its potential effects on the nervous system. The National Institute of Dental and Craniofacial Research and U.S. Air Force investigators collaborated in the ongoing Air Force Health Study (AFHS) of Vietnam era veterans. The primary study question involved adverse health effects associated with exposure to herbicides or dioxin. An assessment of exposure to dental amalgam fillings was added to the 1997-1998 health examination to investigate possible associations between amalgam exposure and neurological abnormalities. Our study population consisted of 1663 dentate AFHS participants, comprised of 986 AFHS controls and 677 Ranch Hand veterans who were exposed to dioxin in Vietnam. Two hundred and fifty-two of the participants had confirmed diabetes mellitus. Study outcomes included clinical neurological signs, vibrotactile thresholds, and summary variables for different levels of peripheral neuropathy. A limitation of our study is that our database did not include more sensitive continuous measures such as nerve conduction studies. No significant associations were found between amalgam exposure and clinical neurological signs of abnormal tremor, coordination, station or gait, strength, sensation, or muscle stretch reflexes or for any level of peripheral neuropathy among our study participants. A statistically significant association was detected between amalgam exposure and the continuous vibrotactile sensation response for the combined non-diabetic participants and separately for non-diabetic AFHS controls. No significant association in this measure was detectable for non-diabetic Ranch Hand veterans or among the combined diabetic participants. The association is a sub-clinical finding that was not associated with symptoms, clinically evident signs of neuropathy, or any functional impairment. Overall, we found no association between amalgam exposure and neurological signs or clinically evident peripheral neuropathy. Our findings do not support the hypothesis that exposure to amalgam produces adverse, clinically evident neurological effects.

AB - Concerns regarding the safety of silver-mercury amalgam fillings continue to be raised in the absence of any direct evidence of harm. The widespread population exposure to amalgam mandated that a thorough investigation be conducted of its potential effects on the nervous system. The National Institute of Dental and Craniofacial Research and U.S. Air Force investigators collaborated in the ongoing Air Force Health Study (AFHS) of Vietnam era veterans. The primary study question involved adverse health effects associated with exposure to herbicides or dioxin. An assessment of exposure to dental amalgam fillings was added to the 1997-1998 health examination to investigate possible associations between amalgam exposure and neurological abnormalities. Our study population consisted of 1663 dentate AFHS participants, comprised of 986 AFHS controls and 677 Ranch Hand veterans who were exposed to dioxin in Vietnam. Two hundred and fifty-two of the participants had confirmed diabetes mellitus. Study outcomes included clinical neurological signs, vibrotactile thresholds, and summary variables for different levels of peripheral neuropathy. A limitation of our study is that our database did not include more sensitive continuous measures such as nerve conduction studies. No significant associations were found between amalgam exposure and clinical neurological signs of abnormal tremor, coordination, station or gait, strength, sensation, or muscle stretch reflexes or for any level of peripheral neuropathy among our study participants. A statistically significant association was detected between amalgam exposure and the continuous vibrotactile sensation response for the combined non-diabetic participants and separately for non-diabetic AFHS controls. No significant association in this measure was detectable for non-diabetic Ranch Hand veterans or among the combined diabetic participants. The association is a sub-clinical finding that was not associated with symptoms, clinically evident signs of neuropathy, or any functional impairment. Overall, we found no association between amalgam exposure and neurological signs or clinically evident peripheral neuropathy. Our findings do not support the hypothesis that exposure to amalgam produces adverse, clinically evident neurological effects.

KW - Amalgam exposure

KW - Epidemiology

KW - Mercury

KW - Neurological signs

KW - Peripheral neuropathy

UR - http://www.scopus.com/inward/record.url?scp=13844294066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844294066&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2004.09.008

DO - 10.1016/j.neuro.2004.09.008

M3 - Article

C2 - 15713345

AN - SCOPUS:13844294066

VL - 26

SP - 241

EP - 255

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

IS - 2

ER -